PharmaBridge International, a Government of India-registered company and a trusted subsidiary of Maahimedicos, is setting ...

First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark COPENHAGEN, DENMARK—21 January 2025 — CSL Behring Denmark today announced that the first ...

K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung ...

Drugmakers, academics and logistics professionals are using artificial intelligence to address the industry’s most pressing ...

Phesi, a global provider of patient-centric data analytics, has released the results of its annual global analysis of all clinical trials conducted in 2024, using data from its AI-driven Trial ...

Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, believes the future of medicine begins with a single drop of blood. From lifesaving blood transfusions to novel ...

Uniphar, a leading global partner to pharmaceutical and medtech manufacturers, announces the appointment of Isaac Batley as Global Head of Medical and Scientific Communications. In this pivotal role, ...

Cambridge Cognition Holdings plc (AIM: COG), the brain health software group specialising in digital products that advance brain health research and treatment, is pleased to announce the launch of its ...

Aravax, a clinical-stage biotechnology company developing precisely targeted next-generation immunotherapies for the treatment of food allergy, today announces the appointment of Aled Williams as ...

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical ...

VANCOUVER, BC / ACCESS Newswire / January 21, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery ...

Development of SalesDocMorris grows 6.7 per cent in 2024 and accelerates Rx growth in the fourth quarter 21.01.2025 / 06:58 CET/CESTPress releaseDocMorris grows 6.7 per cent in 2024 and accelerates Rx ...